170 related articles for article (PubMed ID: 3041048)
1. Novobiocin and coumermycin A1 inhibit viral replication and the reactivation of herpes simplex virus type 1 from the trigeminal ganglia of latently infected mice.
Spivack JG; O'Boyle DR; Fraser NW
J Virol; 1987 Oct; 61(10):3288-91. PubMed ID: 3041048
[TBL] [Abstract][Full Text] [Related]
2. Effect of acyclovir on latent herpes simplex virus infections in trigeminal ganglia of mice.
Klein RJ; DeStefano E; Friedman-Kien AE; Brady E
Antimicrob Agents Chemother; 1981 May; 19(5):937-9. PubMed ID: 6271054
[TBL] [Abstract][Full Text] [Related]
3. Effects of 2,2'-O-cyclocytidine and acyclovir on latent herpes simplex virus in trigeminal ganglia of mice.
Liu WG; Chen ZJ; Song JZ; Ma ZX
Antimicrob Agents Chemother; 1986 Feb; 29(2):278-80. PubMed ID: 2424367
[TBL] [Abstract][Full Text] [Related]
4. Expression of herpes simplex virus type 1 latency-associated transcripts in the trigeminal ganglia of mice during acute infection and reactivation of latent infection.
Spivack JG; Fraser NW
J Virol; 1988 May; 62(5):1479-85. PubMed ID: 2833602
[TBL] [Abstract][Full Text] [Related]
5. In vitro effect of (E)-5-(2-bromovinyl)-2'-deoxyuridine, 5'-amino-5-iodo-2',5'-dideoxyuridine and 2-deoxy-D-glucose on latent ganglionic herpes simplex virus infection.
Pavan-Langston D; Park NH; De Clercq E
Antiviral Res; 1984 Apr; 4(1-2):53-61. PubMed ID: 6331305
[TBL] [Abstract][Full Text] [Related]
6. Effect of novobiocin and other DNA gyrase inhibitors on virus replication and DNA synthesis in herpes simplex virus type 1-infected BHK cells.
Francke B; Margolin J
J Gen Virol; 1981 Feb; 52(Pt 2):401-4. PubMed ID: 6270241
[TBL] [Abstract][Full Text] [Related]
7. Effect of immune serum on the establishment of herpes simplex virus infection in trigeminal ganglia of hairless mice.
Klein RJ
J Gen Virol; 1980 Aug; 49(2):401-5. PubMed ID: 6255074
[TBL] [Abstract][Full Text] [Related]
8. Detection of herpes simplex virus type 1 transcripts during latent infection in mice.
Spivack JG; Fraser NW
J Virol; 1987 Dec; 61(12):3841-7. PubMed ID: 2824818
[TBL] [Abstract][Full Text] [Related]
9. Continued expression of a poly(A)+ transcript of herpes simplex virus type 1 in trigeminal ganglia of latently infected mice.
Puga A; Notkins AL
J Virol; 1987 May; 61(5):1700-3. PubMed ID: 3033297
[TBL] [Abstract][Full Text] [Related]
10. Detection of an immediate early herpes simplex virus type 1 polypeptide in trigeminal ganglia from latently infected animals.
Green MT; Courtney RJ; Dunkel EC
Infect Immun; 1981 Dec; 34(3):987-92. PubMed ID: 7037648
[TBL] [Abstract][Full Text] [Related]
11. Latent herpes simplex virus type 1 transcription in human trigeminal ganglia.
Steiner I; Spivack JG; O'Boyle DR; Lavi E; Fraser NW
J Virol; 1988 Sep; 62(9):3493-6. PubMed ID: 2841498
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies suppress replication of herpes simplex virus type 1 in trigeminal ganglia.
Oakes JE; Lausch RN
J Virol; 1984 Sep; 51(3):656-61. PubMed ID: 6088790
[TBL] [Abstract][Full Text] [Related]
13. A herpes simplex virus type 1 mutant containing a nontransinducing Vmw65 protein establishes latent infection in vivo in the absence of viral replication and reactivates efficiently from explanted trigeminal ganglia.
Steiner I; Spivack JG; Deshmane SL; Ace CI; Preston CM; Fraser NW
J Virol; 1990 Apr; 64(4):1630-8. PubMed ID: 2157048
[TBL] [Abstract][Full Text] [Related]
14. Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs.
Svennerholm B; Vahlne A; Lycke E
Arch Virol; 1981; 69(1):43-8. PubMed ID: 6271097
[TBL] [Abstract][Full Text] [Related]
15. Effects of prolonged cultivation in the presence of acyclovir on recovery of latent herpes simplex virus from human trigeminal ganglia.
Lewis ME; Warren KG; Jeffrey VM; Tyrrell DL
Antimicrob Agents Chemother; 1983 Mar; 23(3):487-9. PubMed ID: 6303216
[TBL] [Abstract][Full Text] [Related]
16. Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.
Coen DM; Kosz-Vnenchak M; Jacobson JG; Leib DA; Bogard CL; Schaffer PA; Tyler KL; Knipe DM
Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4736-40. PubMed ID: 2543985
[TBL] [Abstract][Full Text] [Related]
17. Effect of acyclovir, bromovinyldeoxyuridine, vidarabine, and L-lysine on latent ganglionic herpes simplex virus in vitro.
Park NH; Pavan-Langston D; Declercq E
Am J Med; 1982 Jul; 73(1A):151-4. PubMed ID: 6285706
[TBL] [Abstract][Full Text] [Related]
18. A low thymidine kinase-producing mutant of herpes simplex virus type 1 causes latent trigeminal ganglia infections in mice.
Gordon Y; Gilden DH; Shtram Y; Asher Y; Tabor E; Wellish M; Devlin M; Snipper D; Hadar J; Becker Y
Arch Virol; 1983; 76(1):39-49. PubMed ID: 6305312
[TBL] [Abstract][Full Text] [Related]
19. Characterization of an in vivo reactivation model of herpes simplex virus from mice trigeminal ganglia.
Birmanns B; Reibstein I; Steiner I
J Gen Virol; 1993 Nov; 74 ( Pt 11)():2487-91. PubMed ID: 8245867
[TBL] [Abstract][Full Text] [Related]
20. Detection of HSV-1 proteins prior to the appearance of infectious virus in mouse trigeminal ganglia during reactivation of latent infection.
Wroblewska Z; Savage K; Spivack JG; Fraser NW
Virus Res; 1989 Oct; 14(2):95-106. PubMed ID: 2558462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
